Brian Majors
About Brian Majors
Brian Majors serves as the Vice President and Head of Program Management at ElevateBio, where he has worked since 2021. He has extensive experience in the biotechnology sector, having held various roles at Novartis, Vertex Pharmaceuticals, and Biogen Idec, and holds a PhD in Chemical and Biomolecular Engineering from Johns Hopkins University.
Work at ElevateBio
Brian Majors serves as the Vice President and Head of Program Management at ElevateBio. He has held this position since 2021, contributing to the company's strategic initiatives in the biotechnology sector. His role involves overseeing program management to ensure the successful development and execution of projects within the organization, based in Waltham, Massachusetts.
Experience at Novartis
Brian Majors has extensive experience at Novartis, where he held multiple roles from 2013 to 2018. He worked as a Technology Steward in Manufacturing Science & Technology for two years, followed by a year as Manufacturing Product Support Team Lead. He then advanced to Head of Manufacturing Product Support for another year before becoming the Global Product Lead in the Cell and Gene Therapy Unit.
Previous Role at Vertex Pharmaceuticals
Prior to his current position, Brian Majors was the Vice President, CMC Lead, and Head of CMC Program Management at Vertex Pharmaceuticals from 2020 to 2021. In this role, he was responsible for overseeing the chemistry, manufacturing, and controls aspects of product development.
Background in Biogen Idec
Brian Majors began his career at Biogen Idec, where he worked as Scientist I from 2008 to 2012 and then as Scientist II from 2012 to 2013. His time at Biogen Idec provided him with foundational experience in scientific research and development within the biotechnology industry.
Education and Expertise
Brian Majors holds a PhD in Chemical and Biomolecular Engineering from The Johns Hopkins University. He also earned a Bachelor of Science degree in Chemical Engineering from Cornell University. His educational background equips him with a strong foundation in engineering principles applicable to the biotechnology field.